FDA Seizes 1.5 Million Illegal Vaping Products, Including Elf Bar
By Dennis Thompson HealthDay Reporter
FRIDAY, Dec. 15, 2023 -- Federal agents have seized more than 1.4 million illegal vaping products being smuggled into the United States from China.
A three-day operation at Los Angeles International Airport resulted in the seizure of 41 shipments of illegal e-cigarettes worth more than $18 million, the U.S. Food and Drug Administration said.
The products included the hugely popular brand Elf Bar, as well as other flavored vapes that have been banned by the FDA.
The seized vaping products will be destroyed, the FDA said.
Many of the products were intentionally mis-declared as items like toys, shoes or household items in an attempt to evade customs, the FDA said.
“Those shamelessly attempting to smuggle illegal e-cigarettes, particularly those that appeal to youth, into this country should take heed of today’s announcement,” Brian King, director of the FDA’s Center for Tobacco Products, said in an agency news release. “Federal agencies are on to their antics and will not hesitate to take action.”
“The significant value of these seized products is also a sobering reminder to these bad actors that their time and money would be better spent complying with the law,” King added.
The Campaign for Tobacco-Free Kids applauded the news, noting that Elf Bar was the most commonly used brand among young vapers in the 2023 National Youth Tobacco Survey.
“This is the strongest enforcement action the government has taken to clear the market of illegal flavored e-cigarette products that are addicting our kids and endangering their health,” Yolonda Richardson, president and CEO of the Campaign for Tobacco-Free Kids, said in a statement.
About 2.1 million kids still use e-cigarettes in the United States, according to the federal survey, and nine out of 10 report using flavored products.
Fruit flavors are the most popular, followed by candy, desserts, sweets, mint and menthol.
In May, the FDA had placed companies associated with Elf Bar brand vapes and other illegal e-cigarettes onto an import alert “red list,” which allows the agency to detain products without conducting a full inspection at the time of entry.
The FDA conducted its subsequent operation with U.S. Customs and Border Protection. Prior to the action, agents scoured shipping invoices to identify shipments that could potentially contain illegal products.
The shipments included flavored Elf Bar vapes, as well as other products from Chinese manufacturer iMiracle Shenzhen with names like EB Design, EB Create and Lost Mary.
Other seized brands include Funky Republic, RELX Pod and IPLAY Max.
“The FDA is committed to continuing to stem the flow of illegal e-cigarettes into the United States,” FDA Commissioner Dr. Robert Califf said in the FDA news release. “Unscrupulous companies try everything they can to bring unauthorized, youth-appealing tobacco products into the country. The FDA will remain vigilant, and together with our federal partners, stop these imports before they make it into the hands of our nation’s youth.”
In 2020, the FDA announced that it would crack down on flavored vape and tobacco products.
As of December, the FDA has filed civil money penalty complaints against 38 e-cigarette manufacturers and 67 retailers. The agency also has asked for seven permanent injunctions against firms marketing illegal e-cigarettes.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-16 02:15
Read more
- FDA Approves Alhemo (concizumab-mtci) to Prevent or Reduce Bleeding Episodes in People with Hemophilia A or B with Inhibitors
- FDA Calls for Better Accuracy of Pulse Oximeters in People of Color
- NIH Researchers Discover Novel Class of Anti-Malaria Antibodies
- Upadacitinib Improves Ulcerative Colitis Outcomes at 12 Months
- Datopotamab Deruxtecan Granted Priority Review in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
- More Activity, Less Risk: Tell Your MD How Much You Move
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions